Jagsonpal Pharmaceuticals Ltd has submitted to the Exchange vide letter dated October 03, 2018 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.